Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs - Global Forecast to 2021

Table of Contents

1 INTRODUCTION 17

1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20

2.1 RESEARCH METHODOLOGY STEPS 20
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 21
2.2.1 SECONDARY RESEARCH 21
2.2.2 PRIMARY RESEARCH 22
2.2.2.1 Key Data from Primary Sources 23
2.2.2.2 Key Industry Insights 24
2.3 MARKET SIZE ESTIMATION METHODOLOGY 24
2.3.1 MARKET DATA VALIDATION AND TRIANGULATION 27
2.3.2 ASSUMPTIONS FOR THE STUDY 28

3 EXECUTIVE SUMMARY 29

3.1 INTRODUCTION 29
3.2 CONCLUSION 33

4 PREMIUM INSIGHTS 34

4.1 GENOME EDITING: MARKET OVERVIEW 34
4.2 GEOGRAPHIC ANALYSIS: GENOME EDITING MARKET, BY APPLICATION (2016) 35
4.3 GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021 35
4.4 GENOME EDITING MARKET SIZE, BY APPLICATION, 2016 VS. 2021 36
4.5 GENOME EDITING MARKET SIZE, BY END USER, 2016 VS. 2021 36
4.6 GEOGRAPHICAL SNAPSHOT OF THE GENOME EDITING MARKET 37

5 MARKET OVERVIEW 38

5.1 INTRODUCTION 39
5.2 MARKET DYNAMICS 39
5.2.1 DRIVERS 40
5.2.1.1 Rising government funding and growth in the number of genomics projects 40
5.2.1.2 High prevalence rate of infectious diseases and cancer among patients 41
5.2.1.3 Technological advancements 41
5.2.1.4 Increase in demand for synthetic genes 42
5.2.1.5 Rise in production of genetically modified crops 42
5.2.1.6 Increasing awareness about genomics 42
5.2.1.7 New product launches by industry players 44
5.2.2 RESTRAINTS 44
5.2.2.1 High cost of genomic equipment 44
5.2.2.2 Adverse public perception related to genetic research 45
5.2.3 OPPORTUNITIES 45
5.2.3.1 Use of genome editing in specialized/personalized medicine 45
5.2.3.2 Emerging markets in developing countries 46
5.2.4 CHALLENGES 47
5.2.4.1 Off-target effect of CRISPR 47
5.2.4.2 Shortage of trained professionals 47

6 GLOBAL GENOME EDITING/ENGINEERING MARKET, BY TECHNOLOGY 48

6.1 INTRODUCTION 49
6.2 CRISPR 50
6.3 TALEN 53
6.4 ZFN 55
6.5 ANTISENSE 57
6.6 OTHER TECHNOLOGIES 59

7 GLOBAL GENOME EDITING/GENOME ENGINEERING MARKET,

BY APPLICATION 61
7.1 INTRODUCTION 62
7.2 CELL LINE ENGINEERING 63
7.3 ANIMAL GENETIC ENGINEERING 66
7.4 PLANT GENETIC ENGINEERING 68
7.5 OTHER APPLICATIONS 70

8 GLOBAL GENOME EDITING/ENGINEERING MARKET, BY END USER 73

8.1 INTRODUCTION 74
8.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES 75
8.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 77
8.4 CONTRACT RESEARCH ORGANIZATIONS 79
 

9 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION 81

9.1 INTRODUCTION 82
9.2 NORTH AMERICA 83
9.2.1 U.S. 86
9.2.1.1 Development of gene therapy in the U.S. 86
9.2.1.2 Increasing use of GM crops 86
9.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias in the United States 86
9.2.1.4 Genome editing conferences in the U.S. 87
9.2.1.5 Rising availability of research grants and funding 88
9.2.1.6 Genome Editing Standards Workshop in the U.S. 88
9.2.1.7 Increasing prevalence of cancer 89
9.2.1.8 Strategic developments in the U.S. market 89
9.2.2 CANADA 91
9.2.2.1 Availability of research funding in Canada 91
9.2.2.2 Rising incidence of cancer 91
9.2.2.3 GAPP to intensify genomic R&D 92
9.3 EUROPE 94
9.3.1 CONFERENCES AND MEETINGS IN EUROPE 95
9.3.2 U.K. 97
9.3.2.1 Increased funds, and grants by government bodies 97
9.3.2.2 100,000 Genomes Project in U.K. 97
9.3.3 GERMANY 99
9.3.3.1 Availability of funding for life science research 99
9.3.3.2 Conferences/Meetings/ Symposiums/Workshops in Germany 99
9.3.3.3 ROE 101
9.3.3.4 Spain’s focus on research 101
9.3.3.5 Growth in the Italian biotech and pharma sectors 101
9.3.3.6 Growing research investments in Sweden & Denmark 101
9.4 ASIA-PACIFIC 103
9.4.1 CHINA 106
9.4.1.1 High intensity of R&D activities in China 106
9.4.1.2 Growing focus of global companies on China 106
9.4.2 JAPAN 108
9.4.2.1 Involvement of industry players in the Japanese market: significant developments 108
9.4.2.2 Conferences and symposiums on genetic engineering in Japan 108
9.4.2.3 Focus on cancer research and treatment 109
9.4.3 INDIA 110
9.4.3.1 Emergence of local players in India 110
9.4.3.2 Growth of the pharmaceutical industry in India 111
9.4.3.3 Development of bio-clusters to boost India’s biotechnology industry 111
9.4.4 ROAPAC 113
9.4.4.1 Australia: Availability of financial support for research 113
9.4.4.2 Genome Asia 100K initiative 113
9.4.4.3 Crop research initiatives in Asia 113
9.5 ROW 115
9.5.1 GENETIC TESTING AND GENOMIC ANALYSIS IN THE MIDDLE EAST 116
9.5.2 BRAZIL: INVESTMENTS IN RESEARCH AND INNOVATION CENTERS AND CONFERENCES & WORKSHOPS 116
9.5.3 RISING PREVALENCE OF HIV, CANCER IN AFRICA 116

10 COMPETITIVE LANDSCAPE 119

10.1 OVERVIEW 119
10.2 MARKET SHARE ANALYSIS 120
10.2.1 INTRODUCTION 120
10.2.2 THERMO FISHER SCIENTIFIC, INC. 121
10.2.3 MERCK KGAA 121
10.2.4 HORIZON DISCOVERY GROUP PLC 121
10.3 COMPETITIVE SITUATION AND TRENDS 122
10.3.1 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 123
10.3.2 PRODUCT & SERVICE LAUNCHES 124
10.3.3 ACQUISITIONS 126
10.3.4 EXPANSIONS 127
10.3.5 OTHER STRATEGIES 129
10.4 STRATEGIC BENCHMARKING 130

11 COMPANY PROFILES 131

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 THERMO FISHER SCIENTIFIC, INC. 132
11.2 MERCK KGAA 135
11.3 HORIZON DISCOVERY GROUP PLC 138
11.4 GENSCRIPT USA INC. 141
11.5 SANGAMO BIOSCIENCES, INC. 143
11.6 INTEGRATED DNA TECHNOLOGIES, INC. 145
11.7 LONZA GROUP LTD. 146
11.8 NEW ENGLAND BIOLABS, INC. 148
11.9 ORIGENE TECHNOLOGIES, INC. 150
11.10 TRANSPOSAGEN BIOPHARMACEUTICALS, INC. 151

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
 
12 APPENDIX 152

LIST OF TABLES

TABLE 1 GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 49
TABLE 2 CRISPR-BASED GENOME EDITING MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 50
TABLE 3 NORTH AMERICA: CRISPR-BASED GENOME EDITING MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 51
TABLE 4 EUROPE: CRISPR-BASED GENOME EDITING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 52
TABLE 5 ASIA-PACIFIC: CRISPR-BASED GENOME EDITING MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 52
TABLE 6 TALEN-BASED GENOME EDITING MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 53
TABLE 7 NORTH AMERICA: TALEN-BASED GENOME EDITING MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 54
TABLE 8 EUROPE: TALEN-BASED GENOME EDITING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 54
TABLE 9 ASIA-PACIFIC: TALEN-BASED GENOME EDITING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 54
TABLE 10 ZFN-BASED GENOME EDITING MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 55
TABLE 11 NORTH AMERICA: ZFN-BASED GENOME EDITING MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 56
TABLE 12 EUROPE: ZFN-BASED GENOME EDITING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 56
TABLE 13 ASIA-PACIFIC: ZFN-BASED GENOME EDITING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 56
TABLE 14 ANTISENSE TECHNOLOGY-BASED GENOME EDITING MARKET SIZE,
BY REGION, 2014–2021 (USD MILLION) 57
TABLE 15 NORTH AMERICA: ANTISENSE TECHNOLOGY-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 58
TABLE 16 EUROPE: ANTISENSE TECHNOLOGY-BASED GENOME EDITING MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 58
TABLE 17 ASIA-PACIFIC: ANTISENSE TECHNOLOGY-BASED GENOME EDITING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 58
TABLE 18 OTHER GENOME EDITING TECHNOLOGIES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 59
TABLE 19 NORTH AMERICA: OTHER GENOME EDITING TECHNOLOGIES MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 60
TABLE 20 EUROPE: OTHER GENOME EDITING TECHNOLOGIES MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 60
TABLE 21 ASIA-PACIFIC: OTHER GENOME EDITING TECHNOLOGIES MARKET SIZE,
BY COUNTRY, 2014–2021 (USD MILLION) 60
TABLE 22 GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 62
TABLE 23 GENOME EDITING MARKET SIZE FOR CELL LINE ENGINEERING, BY REGION,
2014–2021 (USD MILLION) 64
TABLE 24 NORTH AMERICA: GENOME EDITING MARKET SIZE FOR CELL LINE ENGINEERING, BY COUNTRY, 2014–2021 (USD MILLION) 65
TABLE 25 EUROPE: GENOME EDITING MARKET SIZE FOR CELL LINE ENGINEERING,
BY COUNTRY/REGION, 2014–2021 (USD MILLION) 65
TABLE 26 ASIA-PACIFIC: GENOME EDITING MARKET SIZE FOR CELL LINE ENGINEERING,
BY COUNTRY/REGION, 2014–2021 (USD MILLION) 65
TABLE 27 GENOME EDITING MARKET SIZE FOR ANIMAL GENETIC ENGINEERING,
BY REGION, 2014–2021 (USD MILLION) 66
TABLE 28 NORTH AMERICA: GENOME EDITING MARKET SIZE FOR ANIMAL GENETIC ENGINEERING, BY COUNTRY, 2014–2021 (USD MILLION) 67
TABLE 29 EUROPE: GENOME EDITING MARKET SIZE FOR ANIMAL GENETIC ENGINEERING,
BY COUNTRY/REGION, 2014–2021 (USD MILLION) 67
TABLE 30 ASIA-PACIFIC: GENOME EDITING MARKET SIZE FOR ANIMAL GENETIC ENGINEERING, BY COUNTRY/REGION, 2014–2021 (USD MILLION) 67
TABLE 31 GENOME EDITING MARKET SIZE FOR PLANT GENETIC ENGINEERING,
BY REGION, 2014–2021 (USD MILLION) 68
TABLE 32 NORTH AMERICA: GENOME EDITING MARKET SIZE FOR PLANT GENETIC ENGINEERING, BY COUNTRY, 2014–2021 (USD MILLION) 69
TABLE 33 EUROPE: GENOME EDITING MARKET SIZE FOR PLANT GENETIC ENGINEERING,
BY COUNTRY/REGION, 2014–2021 (USD MILLION) 69
TABLE 34 ASIA-PACIFIC: GENOME EDITING MARKET SIZE FOR PLANT GENETIC ENGINEERING, BY COUNTRY/REGION, 2014–2021 (USD MILLION) 70
TABLE 35 GENOME EDITING MARKET SIZE FOR OTHER APPLICATIONS, BY REGION,
2014–2021 (USD MILLION) 70
TABLE 36 NORTH AMERICA: GENOME EDITING MARKET SIZE FOR OTHER APPLICATIONS,
BY COUNTRY, 2014–2021 (USD MILLION) 71
TABLE 37 EUROPE: GENOME EDITING MARKET SIZE FOR OTHER APPLICATIONS,
BY COUNTRY/REGION, 2014–2021 (USD MILLION) 71
TABLE 38 ASIA-PACIFIC: GENOME EDITING MARKET SIZE FOR OTHER APPLICATIONS,
BY COUNTRY/REGION, 2014–2021 (USD MILLION) 72
TABLE 39 GLOBAL GENOME EDITING MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 74
TABLE 40 GENOME EDITING MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2014–2021 (USD MILLION) 75
TABLE 41 NORTH AMERICA: GENOME EDITING MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2014–2021 (USD MILLION) 76
TABLE 42 EUROPE: GENOME EDITING MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2014–2021 (USD MILLION) 76
TABLE 43 ASIA-PACIFIC: GENOME EDITING MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2014–2021 (USD MILLION) 76
TABLE 44 GENOME EDITING MARKET SIZE FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2014–2021 (USD MILLION) 77
TABLE 45 NORTH AMERICA: GENOME EDITING MARKET SIZE FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2014–2021 (USD MILLION) 77
TABLE 46 EUROPE: GENOME EDITING MARKET SIZE FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2014–2021 (USD MILLION) 78
TABLE 47 ASIA-PACIFIC: GENOME EDITING MARKET SIZE FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2014–2021 (USD MILLION) 78
TABLE 48 GENOME EDITING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS,
BY REGION, 2014–2021 (USD MILLION) 79
TABLE 49 NORTH AMERICA: GENOME EDITING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 79
TABLE 50 EUROPE: GENOME EDITING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2014–2021 (USD MILLION) 80
TABLE 51 ASIA-PACIFIC: GENOME EDITING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 80
TABLE 52 GENOME EDITING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 82
TABLE 53 NORTH AMERICA: GENOME EDITING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 84
TABLE 54 NORTH AMERICA: GENOME EDITING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 84
TABLE 55 NORTH AMERICA: GENOME EDITING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 85
TABLE 56 NORTH AMERICA: GENOME EDITING MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 85
TABLE 57 U.S.: GENOME EDITING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 90
TABLE 58 U.S.: GENOME EDITING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 90
TABLE 59 U.S.: GENOME EDITING MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 90
TABLE 60 INDICATIVE LIST OF PROJECTS FUNDED BY GAPP IN 2014 92
TABLE 61 CANADA: GENOME EDITING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 92
TABLE 62 CANADA: GENOME EDITING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 93
TABLE 63 CANADA: GENOME EDITING MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 93
TABLE 64 PROMINENT EVENTS IN EUROPE 95
TABLE 65 EUROPE: GENOME EDITING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 95
TABLE 66 EUROPE: GENOME EDITING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 96
TABLE 67 EUROPE: GENOME EDITING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 96
TABLE 68 EUROPE: GENOME EDITING MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 96
TABLE 69 U.K.: GENOME EDITING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 98
TABLE 70 U.K.: GENOME EDITING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 98
TABLE 71 U.K.: GENOME EDITING MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 98
TABLE 72 EVENTS IN GERMANY 99
TABLE 73 GERMANY: GENOME EDITING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 100
TABLE 74 GERMANY: GENOME EDITING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 100
TABLE 75 GERMANY: GENOME EDITING MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 100
TABLE 76 ROE: GENOME EDITING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 102
TABLE 77 ROE: GENOME EDITING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 102
TABLE 78 ROE: GENOME EDITING MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 102
TABLE 79 ASIA-PACIFIC: GENOME EDITING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 104
TABLE 80 ASIA-PACIFIC: GENOME EDITING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 104
TABLE 81 ASIA-PACIFIC: GENOME EDITING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 105
TABLE 82 ASIA-PACIFIC: GENOME EDITING MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 105
TABLE 83 CHINA: GENOME EDITING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 106
TABLE 84 CHINA: GENOME EDITING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 107
TABLE 85 CHINA: GENOME EDITING MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 107
TABLE 86 CONFERENCES, SYMPOSIA, & WORKSHOPS IN JAPAN (2016) 108
TABLE 87 JAPAN: GENOME EDITING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 109
TABLE 88 JAPAN: GENOME EDITING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 109
TABLE 89 JAPAN: GENOME EDITING MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 110
TABLE 90 INDIA: GENOME EDITING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 112
TABLE 91 INDIA: GENOME EDITING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 112
TABLE 92 INDIA: GENOME EDITING MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 112
TABLE 93 ROAPAC: GENOME EDITING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 114
TABLE 94 ROAPAC: GENOME EDITING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 114
TABLE 95 ROAPAC: GENOME EDITING MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 114
TABLE 96 HIV INFECTIONS AND AIDS-RELATED DEATHS IN THE MIDDLE EAST
AND AFRICA, 2014 117
TABLE 97 ROW: GENOME EDITING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 117
TABLE 98 ROW: GENOME EDITING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 117
TABLE 99 ROW: GENOME EDITING MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 118
TABLE 100 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS (2013–2016) 123
TABLE 101 PRODUCT & SERVICE LAUNCHES (2013–2016) 125
TABLE 102 ACQUISITIONS (2013–2016) 126
TABLE 103 EXPANSIONS (2013–2016) 128
TABLE 104 OTHER STRATEGIES (2013–2016) 129
TABLE 105 MARKET DEVELOPMENTS BETWEEN 2013 & 2016 130
 

LIST OF FIGURES

FIGURE 1 GLOBAL GENOME EDITING MARKET SEGMENTATION 18
FIGURE 2 GLOBAL GENOME EDITING MARKET: RESEARCH METHODOLOGY 20
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 23
FIGURE 4 BOTTOM-UP APPROACH 25
FIGURE 5 TOP-DOWN APPROACH 25
FIGURE 6 RESEARCH DESIGN 26
FIGURE 7 DATA TRIANGULATION METHODOLOGY 27
FIGURE 8 GLOBAL GENOME EDITING MARKET ANALYSIS, BY TECHNOLOGY (2016-2021) 29
FIGURE 9 GLOBAL GENOME EDITING MARKET ANALYSIS, BY APPLICATION, 2016 VS. 2021 30
FIGURE 10 GLOBAL GENOME EDITING MARKET ANALYSIS, BY END USER, 2016 VS. 2021 31
FIGURE 11 GLOBAL GENOME EDITING MARKET, BY REGION, 2016 – 2021 32
FIGURE 12 GENOME EDITING MARKET PROJECTED TO WITNESS A DOUBLE-DIGIT GROWTH RATE IN THE FORECAST PERIOD 34
FIGURE 13 CELL LINE ENGINEERING SEGMENT TO DOMINATE THE GENOME EDITING MARKET IN 2016 35
FIGURE 14 CRISPR SEGMENT TO WITNESS THE HIGHEST GROWTH RATE DURING FORECAST PERIOD 35
FIGURE 15 CELL LINE ENGINEERING SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 36
FIGURE 16 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES TO COMMAND THE LARGEST MARKET SHARE IN 2016 36
FIGURE 17 NORTH AMERICA TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 37
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS 39
FIGURE 19 GLOBAL GENOME EDITING MARKET, BY TECHNOLOGY, 2016 VS. 2021 49
FIGURE 20 NORTH AMERICA IS ESTIMATED TO ACCOUNT FOR THE LARGEST SHARE OF CRISPR-BASED GENOME EDITING MARKET 51
FIGURE 21 GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2016 VS. 2021 62
FIGURE 22 NORTH AMERICA IS ESTIMATED TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL LINE ENGINEERING MARKET 64
FIGURE 23 GENOME EDITING MARKET, BY END USER (2016 VS. 2021) 74
FIGURE 24 GENOME EDITING MARKET, BY REGION, 2016 VS. 2021 82
FIGURE 25 NORTH AMERICA: GENOME EDITING MARKET SNAPSHOT 83
FIGURE 26 PREVALENCE OF ALZHEIMER'S DISEASE IN U.S., 2015. 87
FIGURE 27 EUROPE: GENOME EDITING MARKET SNAPSHOT 94
FIGURE 28 ASIA-PACIFIC: GENOME EDITING MARKET SNAPSHOT 103
FIGURE 29 ROW: GENOME EDITING MARKET SNAPSHOT 115
FIGURE 30 AGREEMENTS, PATNERSHIPS AND COLLABORATIONS ARE THE MAJOR STRATEGIES ADOPTED BY THE KEY PLAYERS, 2013–2016 119
FIGURE 31 MARKET SHARE ANALYSIS, BY KEY PLAYER (2015) 120
FIGURE 32 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS 122
FIGURE 33 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS,
BY COMPANY (2013–2016) 123
FIGURE 34 PRODUCT & SERVICE LAUNCHES, BY COMPANY (2013–2016) 124
FIGURE 35 ACQUISITIONS, BY COMPANY (2013–2016) 126
FIGURE 36 EXPANSIONS, BY COMPANY (2013–2016) 127
FIGURE 37 OTHER STRATEGIES, BY COMPANY (2013–2016) 129
FIGURE 38 GEOGRAPHIC REVENUE MIX OF MARKET PLAYERS 131
FIGURE 39 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 132
FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT 135
FIGURE 41 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT 136
FIGURE 42 HORIZON DISCOVERY GROUP PLC: COMPANY SNAPSHOT 138
FIGURE 43 GENSCRIPT USA INC.: COMPANY SNAPSHOT 141
FIGURE 44 SANGAMO BIOSCIENCES, INC.: COMPANY SNAPSHOT 143
FIGURE 45 LONZA GROUP LTD.: COMPANY SNAPSHOT 146

当レポートのプレスリリースは発行されておりません。